112 related articles for article (PubMed ID: 7569020)
21. The effect of TURP on prognosis in prostatic carcinoma.
Kuban DA; el-Mahdi AM; Schellhammer PF
Int J Radiat Oncol Biol Phys; 1987 Nov; 13(11):1653-9. PubMed ID: 3667372
[TBL] [Abstract][Full Text] [Related]
22. Incidental carcinoma of the prostate: significance of staging transurethral resection.
Carroll PR; Leitner TC; Yen TS; Watson RA; Williams RD
J Urol; 1985 May; 133(5):811-4. PubMed ID: 3989921
[TBL] [Abstract][Full Text] [Related]
23. Early endocrine therapy versus radical prostatectomy combined with early endocrine therapy for stage D1 prostate cancer.
Schmeller N; Lubos W
Br J Urol; 1997 Feb; 79(2):226-34. PubMed ID: 9052475
[TBL] [Abstract][Full Text] [Related]
24. Pretreatment transurethral resection of prostate cancer and disease-free survival.
Natarajan N; Mettlin C; Murphy GP; Schmidt J
Anticancer Res; 1987; 7(3 Pt B):395-9. PubMed ID: 3631892
[TBL] [Abstract][Full Text] [Related]
25. [Outcome after radical prostatectomy with extended pelvic lymphadenectomy for untreated high-risk clinically localized prostate cancer].
Tsurusaki T; Yamasaki Y; Maruta S
Nihon Hinyokika Gakkai Zasshi; 2013 May; 104(3):496-504. PubMed ID: 23819361
[TBL] [Abstract][Full Text] [Related]
26. Prostate Biopsy Specimens With Gleason 3+3=6 and Intraductal Carcinoma: Radical Prostatectomy Findings and Clinical Outcomes.
Khani F; Epstein JI
Am J Surg Pathol; 2015 Oct; 39(10):1383-9. PubMed ID: 26076065
[TBL] [Abstract][Full Text] [Related]
27. Ten-year disease free survival after transperineal sonography-guided iodine-125 brachytherapy with or without 45-gray external beam irradiation in the treatment of patients with clinically localized, low to high Gleason grade prostate carcinoma.
Ragde H; Elgamal AA; Snow PB; Brandt J; Bartolucci AA; Nadir BS; Korb LJ
Cancer; 1998 Sep; 83(5):989-1001. PubMed ID: 9731904
[TBL] [Abstract][Full Text] [Related]
28. Definitive external-beam radiotherapy versus radical prostatectomy in clinically localized high-risk prostate cancer: a retrospective study.
Andic F; Izol V; Gokcay S; Arslantas HS; Bayazit Y; Coskun H; Tansug MZ; Sertdemir Y
BMC Urol; 2019 Jan; 19(1):3. PubMed ID: 30611260
[TBL] [Abstract][Full Text] [Related]
29. Nonrandomized evaluation of pelvic lymph node irradiation in localized carcinoma of the prostate.
Perez CA; Michalski J; Brown KC; Lockett MA
Int J Radiat Oncol Biol Phys; 1996 Oct; 36(3):573-84. PubMed ID: 8948341
[TBL] [Abstract][Full Text] [Related]
30. Long-term results of treatment for prostate carcinoma by staging pelvic lymph node dissection and definitive irradiation using low-dose rate temporary iridium-192 interstitial implant and external beam radiotherapy.
Puthawala AA; Syed AM; Austin PA; Cherlow JM; Perley JM; Shanberg AM; Sawyer DE; Ingram JE; Baghdassarian R; Wachs BH; Perley JE; Londrc A; Espinoza-Ferrel T
Cancer; 2001 Oct; 92(8):2084-94. PubMed ID: 11596024
[TBL] [Abstract][Full Text] [Related]
31. A comparison of external beam radiation therapy versus radical prostatectomy for patients with low risk prostate carcinoma diagnosed, staged, and treated at a single institution.
Martinez AA; Gonzalez JA; Chung AK; Kestin LL; Balasubramaniam M; Diokno AC; Ziaja EL; Brabbins DS; Vicini FA
Cancer; 2000 Jan; 88(2):425-32. PubMed ID: 10640977
[TBL] [Abstract][Full Text] [Related]
32. Results of external beam radiotherapy in 448 patients with clinically localized adenocarcinoma of the prostate.
Mameghan H; Fisher R; Mameghan J; Brook S
Aust N Z J Surg; 1994 Jun; 64(6):389-94. PubMed ID: 8010899
[TBL] [Abstract][Full Text] [Related]
33. The impact of prior TURP on radical prostatectomy surgical margins: a multicenter analysis.
Gacci M; Simonato A; Lanciotti M; Ennas M; Varca V; Maffezzini M; Imbimbo C; Gontero P; Schiavina R; Carini M; Martorana G; Nicita G; Mirone V; Carmignani G
Urol Int; 2013; 91(1):62-8. PubMed ID: 23735440
[TBL] [Abstract][Full Text] [Related]
34. Risk of prostate carcinoma death in patients with lymph node metastasis.
Cheng L; Zincke H; Blute ML; Bergstralh EJ; Scherer B; Bostwick DG
Cancer; 2001 Jan; 91(1):66-73. PubMed ID: 11148561
[TBL] [Abstract][Full Text] [Related]
35. Urinary morbidity and incontinence following transurethral resection of the prostate after brachytherapy.
Kollmeier MA; Stock RG; Cesaretti J; Stone NN
J Urol; 2005 Mar; 173(3):808-12. PubMed ID: 15711274
[TBL] [Abstract][Full Text] [Related]
36. Ductal adenocarcinoma of the prostate diagnosed on transurethral biopsy or resection is not always indicative of aggressive disease: implications for clinical management.
Aydin H; Zhang J; Samaratunga H; Tan N; Magi-Galluzzi C; Klein E; Jones JS; Zhou M
BJU Int; 2010 Feb; 105(4):476-80. PubMed ID: 19709071
[TBL] [Abstract][Full Text] [Related]
37. Stage T1-2 prostate cancer: a multivariate analysis of factors affecting biochemical and clinical failures after radical prostatectomy.
Kupelian PA; Katcher J; Levin HS; Klein EA
Int J Radiat Oncol Biol Phys; 1997 Mar; 37(5):1043-52. PubMed ID: 9169811
[TBL] [Abstract][Full Text] [Related]
38. Prostate-specific antigen for pretreatment prediction and posttreatment evaluation of outcome after definitive irradiation for prostate cancer.
Kuban DA; el-Mahdi AM; Schellhammer PF
Int J Radiat Oncol Biol Phys; 1995 May; 32(2):307-16. PubMed ID: 7538499
[TBL] [Abstract][Full Text] [Related]
39. Morbidity and mortality of local failure after definitive therapy for prostate cancer.
Schellhammer PF; Whitmore RB; Kuban DA; el-Mahdi AM; Ladaga LA
J Urol; 1989 Mar; 141(3):567-71. PubMed ID: 2918594
[TBL] [Abstract][Full Text] [Related]
40. [Treatment of localized prostate cancer: radical prostatectomy versus radiation therapy].
Kanamaru H; Akino H; Mori H; Okada K; Arai Y
Hinyokika Kiyo; 1996 Oct; 42(10):817-20. PubMed ID: 8951481
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
